-
2025-524181-26-00
4
relapsed/refractory multiple myeloma
-
2025-524302-15-00
4
Gastrointestinal Acute Graft-versus-Host Disease (GI-aGvHD)
-
2025-521976-80-00
4
2026-05-28
Relapsed or Refractory
Multiple Myeloma (RRMM)
-
2025-524001-33-00
4
2026-05-22
Graves’ Disease
-
2025-523431-19-00
4
2026-05-20
Idiopathic Pulmonary Fibrosis (IPF)
-
2025-521903-28-00
5
2026-05-06
Adenovirus viremia
-
2024-519699-24-00
4
2026-04-23
IgA nephropathy
-
2025-521752-26-00
4
2026-04-22
Complement-Mediated Kidney Disease
-
2024-517943-29-00
5
2026-04-21
Pulmonary Hypertension associated with interstitial lung disease (WHO
-
2025-522191-86-00
5
2026-04-02
Focal segmental glomerulosclerosis
-
2025-522279-27-00
5
2026-04-02
Newly Diagnosed AML with an NPM1 mutation
-
2025-520805-10-00
5
2026-03-12
Chronic inflammatory demyelinating polyneuropathy (CIDP)
-
2025-522553-19-00
10
2026-02-25
Symptomatic genetic and familial dilated cardiomyopathy.
-
2024-515332-80-00
5
2026-02-23
Bacterial vaginosis
-
2024-516216-16-00
5
2026-02-13
Invasive mold infections caused by Aspergillus spp., Fusarium spp., Lo
-
2025-521558-40-00
5
2026-02-12
Pulmonary Hypertension Associated with Interstitial Lung Disease
-
2025-521831-35-00
6
2026-02-12
Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
-
2024-520097-36-00
5
2026-01-07
Chronic inflammatory demyelinating polyneuropathy (CIDP)
-
2025-522052-13-00
10
2025-12-24
Framework for Optimizing, Refining, and Unifying Management of HSCT in
-
2024-510778-26-00
4
2025-12-19
Metastatic Non-Small-Cell Lung Cancer
-
2024-518899-31-00
5
2025-12-19
Variant or wild-type transthyretin (TTR) amyloid cardiomyopathy
-
2025-522669-32-00
5
2025-12-18
Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lym
-
2024-519901-36-00
5
2025-12-17
Patients with resected stage II-IIIA non-small cell lung cancer (NSCLC
-
2025-521775-31-00
5
2025-11-12
Stage IB-IIIA NSCLC Patients with uncommon EGFR Mutations